CIK 0001274737 · Non-accelerated filer<br>Smaller reporting company
EXAGEN INC.
Sign in to watch- Ticker
- XGN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (760) 560-1501
- Business address
- 1261 LIBERTY WAY, VISTA, CA, 92081
- Former names
- EXAGEN DIAGNOSTICS INC
- Open-market buys, last 90 days
- $568,660
- in 3 filings
- Open-market sales, last 90 days
- $487,740
- in 3 filings
Net +$80,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-01 | Hazeltine Mark Chief Operating Officer | Shares withheld for taxes | −3,241 | $7.12 | $23K | 99,693 |
| 2022-03-01 | Adawi Kamal CFO and Corporate Secretary | Shares withheld for taxes | −3,241 | $7.12 | $23K | 97,759 |
| 2022-03-01 | Rocca Fortunato R. President and CEO | Shares withheld for taxes | −4,322 | $7.12 | $31K | 120,678 |
| 2022-02-04 | Zack Debra Chief Medical Officer | Grant or award | +50,000 | 87,500 | ||
| 2022-02-04 | Hazeltine Mark Chief Operating Officer | Grant or award | +63,500 | 102,934 | ||
| 2022-02-04 | Adawi Kamal CFO and Corporate Secretary | Grant or award | +63,500 | 101,000 | ||
| 2022-02-04 | Rocca Fortunato R. President and CEO | Grant or award | +75,000 | 125,000 | ||
| 2021-09-03 | Johnson Wendy S. Director | Purchase | +1,000 | $14.02 | $14K | 1,000 |
| 2021-08-05 | TULLIS JAMES L L Director | Sale | −6,800 | $10.72 | $73K | 1,515,672 |
| 2021-08-04 | TULLIS JAMES L L Director | Sale | −2,100 | $11.39 | $24K | 1,522,472 |
| 2021-08-03 | TULLIS JAMES L L Director | Sale | −4,300 | $11.77 | $51K | 1,524,572 |
| 2021-08-02 | TULLIS JAMES L L Director | Sale | −1,800 | $11.92 | $21K | 1,528,872 |
| 2021-07-29 | Hooker Ana Director | Grant or award · Stock Option(right to buy) | +15,000 | 15,000 | ||
| 2021-06-29 | TULLIS JAMES L L Director | Sale | −5,379 | $14.67 | $79K | 1,530,672 |
| 2021-06-28 | TULLIS JAMES L L Director | Sale | −10,858 | $14.98 | $163K | 1,536,051 |
| 2021-06-25 | TULLIS JAMES L L Director | Sale | −8,763 | $16.03 | $141K | 1,546,909 |
| 2021-06-17 | PALLARES EBETUEL Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2021-06-17 | Stokes Frank Director | Grant or award · Stock Option(right to buy) | +15,000 | 15,000 | ||
| 2021-06-17 | Robertson Bruce C Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2021-06-17 | Nova Tina Susan Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 |
Page 5 of 7 · 126 trades